REVANESSE CONTOUR+ (2x1,2ml) PROLLENIUM

REVANESSE CONTOUR+ with Lidocaine (2x1,2ml) PROLLENIUM

MEDICAL USE. Medical device. Should be used by trained members of the medical profession only. REVANESSE is injected by qualified, trained doctors into the dermis of patients.

DESCRIPTION

REVANESSE CONTOUR + is a colorless, odorless, transparent and aqueous gel of synthetic origin. The gel is stored in a pre-filled disposable syringe. Each box contains two 1.2ml syringes of REVANESSE CONTOUR + along with two sterilized 27G needles. REVANESSE CONTOUR is an ultra-high viscosity HA gel used to treat large volume areas by contouring and shaping. REVANESSE CONTOUR is ideal for areas that require larger volumetric adjustments. To treat large volume areas by contouring and shaping. It is said to be ideal for large volume treatments, mid face volumisation, chin and jaw augmentation and nose bride correction. REVANESSE CONTOUR is the newest member of the REVANESSE family of dermal fillers and is designed to provide ultra high viscosity and long lasting results. Incorporates Thixofixcross-linking technology, resulting in high quality, safe and long-lasting dermal fillers. REVANESSE CONTOUR is a monophasic, non-animal hyaluronic acid based dermal filler brands manufactured in Canada by Prollenium and distributed in the UK by Boston Medical Group Ltd since 2010. 

COMPOSITION

Cross-linked hyaluronic acid (High Viscosity) 25mg/ml + Lidocaine 0.3% w/w. In phosphate buffered saline. [Cross linked with Butandiol-diglycidylether (BDDE)].

APPLICATION RANGE / INDICATIONS

REVANESSE CONTOUR is designed to restore and add volume to the face, as well as shapes and contours facial features using hyaluronic acid gel that is perfect for large volume treatments. Volumising contouring. REVANESSE CONTOUR + is a cross linked hyaluronic acid gel that is indicated for the treatment of medium to deep facial rhytides and lipoatrophy by injection into the middle part of the dermis layer. Implantation life is dependent on depth and location of injection, and averages 6-12 months.

DETAILS

• 2 serynges x 1,2 ml.
• COMPOSITION: HYALURONIC ACID CROSSLINKED 25 mg / ml. High Viscosity25mg/ml. In phosphate buffered saline. [Cross-linked with Butanediol-diglycidylether (BDDE)]. Cross-linked BDDE +++++
• Lidocain 0.3% w/w.
• NEEDLE : 27G 
• IDEAL FOR : Volumetric Contouring
• SHAPE RETENTION / LIFT CAPACITY: 7/5 
• DURATION: 12 to 18 months 
• COMMON TREATMENT AREAS: Temples, Cheeks, Chin, Jawline.
• INJECTION DEPTH DEEP DERMIS TO SUBCUTANEOUS. 
• ULTRA-HIGH VISCOSITY Specially formulated for areas that need volume restoration or contouring. 
• INDICATIONS: REVANESSE CONTOUR is a cross linked hyaluronic acid gel that is indicated for the treatment of facial rhytides and lipoatrophy by injection into the skin.
• Implantation life is dependent on depth and location of injection, and averages 6-12 months.
• Ideal for large volume treatments, volumization of the middle face, chin and jaw augmentation and nose correction. Deep folds, lines and wrinkles. Glabellar lines (eyebrows). Cheek Nose bridge. Chin and jaw.
• REVANESSE CONTOUR+ is a thick, high viscosity hyaluronic acid (HA) gel that can be used to treat other large volume areas and help to sculpt and contour for a firm, lifted appearance.

CONDITIONNEMENT

• 2 Syringes Pre-filled x 1,2ml per pack + needles 27G.
• 2 x 1,2ml, 25mg/ml of high viscosity HA.
• The gel is delivered in a pre-filled disposableglass syringe.
• Each box of REVANESSE contains two 1.2 mL syringes of REVANESSE along with two sterile needles.

INDICATIONS

To treat large volume areas by contouring and shaping. Deep folds, lines and wrinkles, glabellar lines (brows), cheeks, nose bridge, chin, and jaw.

INJECTION DEPTH

Deep dermis and subcutaneous.

THE REVANESSE FAMILY LINE

The REVANESSE family of products is a collection of injectable dermal fillers that are used to treat signs of aging. The products have been developed to smooth out lines and wrinkles, shape and contour facial features and add volume, creating a more youthful look. REVANESSE family of products incorporates the latest advancements in cross-linking technology, resulting in a high quality, safe and long lasting dermal filler. The Hyaluronic acid utilised in REVANESSE is naturally integrated into the tissue, keeping the skin looking healthy and natural.

• CONTOUR +: CROSS-LINKED HYALURONIC ACID 25 mg/ml + LIDOCAINE
• KISS +: CROSS-LINKED HYALURONIC ACID 25 mg/ml + LIDOCAINE
• OUTLINE +: CROSS-LINKED HYALURONIC ACID 25 mg/ml + LIDOCAINE
• PURE +: NON-CROSSLINKED HYALURONIC ACID 14 mg + LIDOCAINE
• REVISE +: CROSS-LINKED HYALURONIC ACID 25 mg/ml + LIDOCAINE
• SHAPE +: CROSS-LINKED HYALURONIC ACID 25 mg/ml + LIDOCAINE
• ULTRA +: CROSS-LINKED HYALURONIC ACID 25 mg/ml + LIDOCAINE.

ABOUT PROLLENIUM

A Canadian company founded in 2002, Prollenium Medical Technologies develops cutting edge products in the medical devices industry. Prollenium’s paramount product, Revanesse, is a line of cross-linked hyaluronic acid (HA) dermal fillers – a true example of our attention to detail and end-to-end capabilities. REVANESSE is developed, manufactured and distributed by Prollenium in Ontario, Canada. We accredit Revanesse’s success to our commitment to quality, attention to detail, best in class manufacturing standards and hands-on oversight. Today, Revanesse can be found in over 80 countries worldwide.